| ★ |  Looking Beyond ALP Response in PBC With Saroglitazar, With Raj Vuppalanchi, MD | | 68 | Estados Unidos | |
| 6 |  The Cholesterol War Is Over (Here's Who Won) | Dr Brad Stanfield @drbradstanfield | 147.6K | Nueva Zelanda | 84 |
| 15 |  Impacto Situacional - Los Farmacos Para Adelgazar y El Peligro En la Sociedad | Impacto Situacional @impactosituacional | 11.7K | Estados Unidos | 84 |
| 7 |  Healing Inflammation Naturally: A Case of Cardiac Sarcoidosis | Montgomery Heart & Wellness @montgomeryheartwellness | 4.8K | Estados Unidos | 84 |
| 8 |  Don't Be Scammed By Bile Salts | | 3.4K | — | 84 |
| 11 |  CagriSema: The Next Gen GLP1? #glp1 #news #healthandwellnessforseniors #semaglutide #wegovy | Dr. G's Lifestyle Medicine Network @gooddrg | 3.2K | Estados Unidos | 84 |
| 12 |  COLANGITE BILIARE PRIMITIVA: LE NUOVE CLASSI DI FARMACI MIGLIORANO PROGNOSI E QUALITA' DI VITA | MedicinaInformazione @medicinainformazione | 912 | Italia | 84 |
| 18 |  Liver Lineup: Bepirovirsen and the Push Toward Functional Cure in Hepatitis B | | 521 | Estados Unidos | 84 |
| 10 |  SGLT2 EN ERC Beneficio en todos los estadios | ENSEÑANDO MEDICINA INTERNA @carloswaldomi | 383 | — | 84 |
| 20 |  GDF2026 - Q&A Discussion Panel Four and Day One Closing | U.S. Food and Drug Administration @us_fda | 187 | Estados Unidos | 84 |
| 13 |  Functional Cures for T1D: Insulin Independence Through Islet Transplantation | | 185 | Estados Unidos | 84 |
| 17 |  Diabetes Dialogue: CKM Systems, Triple Agonists, and a Sensor Scandal Ahead of ADA | | 179 | Estados Unidos | 84 |
| 4 |  Diabetes Dialogue: Tegoprubart and Freedom from Insulin in Type 1 Diabetes | | 143 | Estados Unidos | 85 |
| 9 |  Adiós al Efecto Tyndall: La ciencia de los Polinucleótidos vs. Ácido Hialurónico. @cosmeticlatam | INDUSTRIA COSMETICA B2B @cosmeticlatam | 143 | Estados Unidos | 84 |
| 3 |  Volixibat Improves Itch, Fatigue in PSC, Supporting “Patient-Centered” Care, With Gideon Hirschfield | | 134 | Estados Unidos | 85 |
| 2 |  Volixibat Improves Itch, Fatigue in PSC, Supporting “Patient-Centered” Care | | 59 | Estados Unidos | 85 |
| 19 |  #62: GLP-1s: Life-Changing Results… at What Cost? | Live Long and Well With Dr. Bobby @drbobbylivelongandwell | 56 | Estados Unidos | 84 |
| 1 |  Saroglitazar Targets Bile Acid Dysregulation, Inflammation in PBC, With Raj Vuppalanchi, MD | | 55 | Estados Unidos | 95 |
| 5 |  Diabetes Dialogue: Teplizumab, Stelo, and Inhaled Insulin Afrezza for Pediatric Patients | | 53 | Estados Unidos | 85 |
| 16 |  Continuous Ketone Monitoring May Guide SGLT2i Use in T1D | | 33 | Estados Unidos | 84 |
| 14 |  B-Cell–Targeted Therapies Expand in IgA Nephropathy, With Samir Parikh, MD | | 27 | Estados Unidos | 84 |